The DOI matches its Crossref record; 25 of the 27 references it cites were found in a registry or an index.
The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery
Abstract
Studies of neurocognitive function in patients with schizophrenia use widely variable assessment techniques. Clinical trials assessing the cognitive enhancing effect of new medications have used neurocognitive assessment batteries that differed in content, length and administration procedures. The Brief Assessment of Cognition in Schizophrenia (BACS) is a newly developed instrument that assesses the aspects of cognition found to be most impaired and most strongly correlated with outcome in patients with schizophrenia. The BACS requires less than 35 min to complete in patients with schizophrenia, yields a high completion rate in these patients, and has high reliability. The BACS was found to be as sensitive to cognitive impairment in patients with schizophrenia as a standard battery of tests that required over 2 h to administer. Compared to healthy controls matched for age and parental education, patients with schizophrenia performed 1.49 standard deviations lower on a composite score calculated from the BACS and 1.61 standard deviations lower on a composite score calculated from the standard battery. The BACS composite scores were highly correlated with the standard battery composite scores in patients (r=0.76) and healthy controls (r=0.90). These psychometric properties make the BACS a promising tool for assessing cognition repeatedly in patients with schizophrenia, especially in clinical trials of cognitive enhancement.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Our search revealed the use of neuropsychological test batteries other than the MCCB (eg, BACS,23 CANTAB,24 and CSSB25), though their use is somewhat limited in the ongoing trials.”
From Clinical trials of potential cognitive-enhancing drugs in schizophrenia: what have we learned so far? (2013) · cites this paper as [23]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
A new rating scale for Alzheimer's disease
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.1356 · Cited by 4,175
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Green, M. F., Kern, R. S., Braff, D. L., & Mintz, J. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033430 · Cited by 2,999
(1995) · Cited by 2,809
Neurocognitive deficit in schizophrenia: A quantitative review of the evidence.
Heinrichs, R. W., & Zakzanis, K. K. (1998) · Neuropsychology · doi:10.1037/0894-4105.12.3.426 · Cited by 2,798
Neuropsychological Function in Schizophrenia
Saykin, A. J. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810310036007 · Cited by 1,160
Auditory Working Memory and Wisconsin Card Sorting Test Performance in Schizophrenia
Gold, J. M. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830140071013 · Cited by 823
Impaired Attention, Genetics, and the Pathophysiology of Schizophrenia
Cornblatt, B. A., & Keilp, J. G. (1994) · Schizophrenia Bulletin · doi:10.1093/schbul/20.1.31 · Cited by 666
Studies of Cognitive Change in Patients With Schizophrenia Following Novel Antipsychotic Treatment
Harvey, P. D., & Keefe, R. S. E. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.2.176 · Cited by 617
Flagged first, then by citations
2 of the 27 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 701–800 of 1,000
Chumakov, E. M., Dorofeikova, M., Александровна, Ц. К., & Petrova, N. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.943869 · Cited by 16
The Effect of Antipsychotics on Cognition in Schizophrenia—A Current Narrative Review
Lungu, P. F., Lungu, C. M., Ciobica, A. S., Balmuș, I.-M., Vitalaru, R., Mavroudis, I. A., Dobrin, R., Cîmpeanu, M., & Gurzu, I. L. (2024) · Brain Sciences · doi:10.3390/brainsci14040359 · Cited by 16
Brand, B. A., de Boer, J. N., Willemse, E. J. M., Weickert, C. S., Sommer, I. E., & Weickert, T. W. (2024) · Archives of Women s Mental Health · doi:10.1007/s00737-024-01491-9 · Cited by 16
Thai, H., Audet, É. C., Koestner, R., Lepage, M., & O’Driscoll, G. A. (2024) · Clinical Psychology Review · doi:10.1016/j.cpr.2024.102471 · Cited by 24
Altamura, A. C., Caletti, E., Paoli, R. A., Cigliobianco, M., Zugno, E., Grillo, P., Prunas, C., Caldiroli, A., & Zago, S. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.08.034 · Cited by 20
Hufford, M. R., Davis, V. G., Hilt, D. C., Dgetluck, N., Geffen, Y., Loebel, A. D., Haig, G. M., Santarelli, L., & Keefe, R. S. E. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.07.018 · Cited by 16
Gooding, A. L., Saperstein, A. M., Mindt, M. R., & Medalia, A. A. (2012) · Neuropsychological Rehabilitation · doi:10.1080/09602011.2012.665583 · Cited by 16
Association of fronto-temporal function with cognitive ability in schizophrenia
Pu, S., Nakagome, K., Itakura, M., Iwata, M., Nagata, I., & Kaneko, K. (2017) · Scientific Reports · doi:10.1038/srep42858 · Cited by 17
Cardiovascular Pharmacogenomics and Cognitive Function in Patients with Schizophrenia
Ward, K. M., Kraal, A. Z., Flowers, S. A., & Ellingrod, V. L. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1968 · Cited by 17
Saitô, S., Fujii, K., Ozeki, Y., Ohmori, K., Honda, G., Mori, H., Kato, K., Kuroda, J., Aoki, A., Asahi, H., et al. (2017) · Bipolar Disorders · doi:10.1111/bdi.12521 · Cited by 16
Veddum, L., Pedersen, H. L., Landert, A.-S. L., & Bliksted, V. (2019) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2018.1554697 · Cited by 16
UP'S: A Cohort Study on Recovery in Psychotic Disorder Patients: Design Protocol
van Aken, B. C., Bakia, A., Wierdsma, A. I., Voskes, Y., van Weeghel, J., van Bussel, E. M. M., Hagestein, C., Ruissen, A. M., Leendertse, P., Sewbalak, W. V., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.609530 · Cited by 17
Lin, J., Su, Y., Shi, C., Liu, Q., Wang, G., Wei, J., Zhu, G., Chen, Q., Tian, H., Zhang, K., et al. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.02.068 · Cited by 17
Bulubas, L., Goerigk, S. A., Gomes, J. S., Brem, A., de Carvalho, J. B., Pinto, B. S., Elkis, H., Gattaz, W. F., Padberg, F., Brunoni, A. R., et al. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.07.008 · Cited by 16
Definition and Measurement of Neurocognition and Social Cognition
Kern, R. S., & Horan, W. P. (2010) · Key issues in mental health (Online)/Key issues in mental health (Print) · doi:10.1159/000284375 · Cited by 16
Tolvaptan: a new tool for the effective treatment of hyponatremia in psychotic disorders
Josiassen, R. C., Curtis, J. L., Filmyer, D. M., Audino, B., Skuban, N., & Shaughnessy, R. A. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656561003610656 · Cited by 17
Bromley, E. (2007) · Psychiatric Services · doi:10.1176/appi.ps.58.4.475 · Cited by 16
French Validation of the Screen for Cognitive Impairment in Psychiatry (SCIP-F)
Tourjman, V., Beauchamp, M. H., Djouini, A., Neugnot-Cerioli, M., Gagner, C., Baruch, P., Beaulieu, S., Chanut, F., Daigneault, A., Juster, R., et al. (2016) · Open Journal of Psychiatry · doi:10.4236/ojpsych.2016.61013 · Cited by 16
Blood Biomarkers Predict the Cognitive Effects of Aripiprazole in Patients with Acute Schizophrenia
Hori, H., Yoshimura, R., Katsuki, A., Atake, K., Igata, R., Konishi, Y., Beppu, H., & Tominaga, H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030568 · Cited by 16
Neurobiology of cognitive remediation in schizophrenia: Effects of EAAT2 polymorphism
Spangaro, M., Bosia, M., Bechi, M., Buonocore, M., Cocchi, F., Guglielmino, C., Bianchi, L. K., Mastromatteo, A. R., Lorenzi, C., & Cavallaro, R. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.06.059 · Cited by 16
Porcelli, S., Marsano, A., Caletti, E., Sala, M., Abbiati, V., Bellani, M., Perlini, C., Rossetti, M. G., Mandolini, G. M., Pigoni, A., et al. (2017) · Neuropsychobiology · doi:10.1159/000490955 · Cited by 15
Exploring anxiety in schizophrenia: New light on a hidden figure
Buonocore, M., Bosia, M., Baraldi, M. A., Bechi, M., Spangaro, M., Cocchi, F., Bianchi, L., Guglielmino, C., Mastromatteo, A. R., & Cavallaro, R. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.07.039 · Cited by 16
Goal-directed planning and action impairments in schizophrenia evaluated in a virtual environment
Siddiqui, I., Saperia, S., Fervaha, G., Silva, S. D., Jeffay, E., Zakzanis, K. K., Agid, O., Remington, G. J., & Foussias, G. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.10.012 · Cited by 16
Santo, F. D., Barnham, I. J., González-Blanco, L., García‐Portilla, M. P., Bobes, J., & Fernández-Egea, E. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.01.016 · Cited by 16
Wright, A. C., Davies, G., Fowler, D., & Greenwood, K. E. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sby155 · Cited by 15
Glenthøj, L. B., Bailey, B. K., Kristensen, T. D., Wenneberg, C., Hjorthøj, C. R., & Nordentoft, M. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13117 · Cited by 15
Reduced white matter microstructure in bipolar disorder with and without psychosis
Brown, J. A., Jackson, B. S., Burton, C. R., Hoy, J. E., Sweeney, J. A., Pearlson, G. D., Keshavan, M. S., Keedy, S., Gershon, E. S., Tamminga, C. A., et al. (2021) · Bipolar Disorders · doi:10.1111/bdi.13055 · Cited by 17
Higuchi, Y., Sumiyoshi, T., Tateno, T., Nakajima, S., Sasabayashi, D., Nishiyama, S., Mizukami, Y., Takahashi, T., & Suzuki, M. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11050327 · Cited by 16
Computerized Assessment of Psychosis Risk
Mittal, V. A., Ellman, L. M., Strauss, G. P., Walker, E. F., Corlett, P. R., Schiffman, J. E., Woods, S. W., Powers, A. R., Silverstein, S. M., Waltz, J. A., et al. (2021) · Journal of Psychiatry and Brain Science · doi:10.20900/jpbs.20210011 · Cited by 18
Bornheimer, L. A., Cobia, D. J., Verdugo, J. L., Holzworth, J., & Smith, M. J. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.01.006 · Cited by 19
Clementz, B. A., Chattopadhyay, I., Trotti, R. L., Parker, D., Gershon, E. S., Hill, S. K., Ivleva, E. I., Keedy, S., Keshavan, M. S., McDowell, J. E., et al. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.08.006 · Cited by 15
Aberrant brain dynamics of large-scale functional networks across schizophrenia and mood disorder
Ishida, T., Yamada, S., Yasuda, K., Uenishi, S., Tamaki, A., Tabata, M., Ikeda, N., Takahashi, S., & Kimoto, S. (2024) · NeuroImage Clinical · doi:10.1016/j.nicl.2024.103574 · Cited by 15
Psychedelics and schizophrenia: a double-edged sword
Sapienza, J., Martini, F., Comai, S., Cavallaro, R., Spangaro, M., Gregorio, D. D., & Bosia, M. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02743-x · Cited by 20
Yang, Z., Heaukulani, C., Sim, A., Buddhika, T., Rashid, N. A. A., Wang, X., Zheng, S., Quek, Y. F., Basu, S., Lee, K. W., et al. (2025) · JMIR mhealth and uhealth · doi:10.2196/56185 · Cited by 15
Abnormal GABAergic function and face processing in schizophrenia: A pharmacologic-fMRI study
Tso, I. F., Fang, Y., Phan, K. L., Welsh, R. C., & Taylor, S. F. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.08.022 · Cited by 15
Differential blood-based biomarkers of psychopathological dimensions of schizophrenia
García-Álvarez, L., García‐Portilla, M. P., González-Blanco, L., Martinez, P. A. S., de la Fuente-Tomás, L., Menéndez-Miranda, I., García, C. I., & Bobes, J. (2016) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/j.rpsmen.2016.04.008 · Cited by 15
Oxytocin Receptor (OXTR) Methylation and Cognition in Psychotic Disorders
Grove, T. B., Burghardt, K. J., Kraal, A. Z., Dougherty, R. J., Taylor, S. F., & Ellingrod, V. L. (2016) · Complex Psychiatry · doi:10.1159/000448173 · Cited by 15
Establishing the Brief Assessment of Cognition - Short form
Lam, M., Wang, M., Huang, W., Eng, G. K., Rapisarda, A., Kraus, M., Kang, S., Keefe, R. S. E., & Lee, J. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.05.006 · Cited by 14
Kanie, A., Kikuchi, A., Haga, D., Tanaka, Y., Ishida, A., Yorozuya, Y., Matsuda, Y., Morimoto, T., Fukuoka, T., Takazawa, S., et al. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00589 · Cited by 15
Bechi, M., Agostoni, G., Buonocore, M., Gritti, D., Mascia, M., Spangaro, M., Bianchi, L., Cocchi, F., Guglielmino, C., Bosia, M., et al. (2019) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2019.100164 · Cited by 15
Ho, N. F., Tng, J. X. J., Wang, M., Chen, G., Subbaraju, V., Shukor, S., Ng, D., Tan, B., Puang, S. J., Kho, S.-H., et al. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.03.013 · Cited by 15
Omega‐3 fatty acids and neurocognitive ability in young people at ultra‐high risk for psychosis
McLaverty, A., Allott, K., Berger, M., Hester, R., McGorry, P. D., Nelson, B., Markulev, C., Yuen, H. P., Schäfer, M. R., Mossaheb, N., et al. (2020) · Early Intervention in Psychiatry · doi:10.1111/eip.13025 · Cited by 16
Haining, K., Brunner, G., Gajwani, R., Groß, J., Gumley, A. I., Lawrie, S. M., Schwannauer, M., Schultze‐Lutter, F., & Uhlhaas, P. J. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.02.019 · Cited by 16
Christensen, T. N., Wallstrøm, I. G., Bojesen, A. B., Nordentoft, M., & Eplov, L. F. (2021) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-021-02107-8 · Cited by 15
van Aken, B. C., Wierdsma, A. I., Voskes, Y., Pijnenborg, G. H. M., van Weeghel, J., & Mulder, C. L. (2022) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgac023 · Cited by 15
Pinna, F., Bosia, M., Cavallaro, R., & Carpiniello, B. (2014) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2014.11.001 · Cited by 15
Hjorthøj, C. R., Fohlmann, A., Larsen, A., Madsen, M. T. R., Vesterager, L., Gluud, C. N., Arendt, M. C. B. B., & Nordentoft, M. (2008) · Trials · doi:10.1186/1745-6215-9-42 · Cited by 15
Intérêt d’un nouvel instrument dans l’évaluation cognitive dans la schizophrénie
Bralet, M., Navarre, M., Eskenazi, A.-M., Lucas-Ross, M., & Falissard, B. (2008) · L Encéphale · doi:10.1016/j.encep.2007.12.005 · Cited by 15
Theory of mind deficits partly mediate impaired social decision-making in schizophrenia
Yang, L., Li, P., Mao, H., Wang, H., Shu, C., Bliksted, V., & Zhou, Y. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1313-3 · Cited by 15
Takahashi, T., Higuchi, Y., Komori, Y., Nishiyama, S., Takayanagi, Y., Sasabayashi, D., Kido, M., Furuichi, A., Nishikawa, Y., Nakamura, M., et al. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00574 · Cited by 16
Friedman‐Yakoobian, M. S., Parrish, E. M., Thomas, A. R., Lesser, R., Gnong-Granato, A., Eack, S. M., & Keshavan, M. S. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.01.029 · Cited by 15
Guo, J. Y., Niendam, T. A., Auther, A. M., Carrión, R. E., Cornblatt, B. A., Ragland, J. D., Adelsheim, S. N., Calkins, R., Sale, T. G., Taylor, S. F., et al. (2019) · Psychological Medicine · doi:10.1017/s0033291719002332 · Cited by 17
Davidson, M., Levi, L. W., Park, J., Nastas, I., Ford, L., Rassnick, S., Canuso, C. M., Davis, J. M., & Weiser, M. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.04.020 · Cited by 15
Haddad, C., Salameh, P., Sacre, H., Clément, J., & Calvet, B. (2022) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2022.103029 · Cited by 14
Cognitive remediation in schizophrenia: What happens after 10 years?
Buonocore, M., Spangaro, M., Bechi, M., Trezzani, S., Terragni, R., Martini, F., Agostoni, G., Cocchi, F., Cuoco, F., Guglielmino, C., et al. (2022) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2022.100251 · Cited by 14
Isayeva, U., Manchia, M., Collu, R., Primavera, D., Deriu, L., Caboni, E., Iaselli, M. N., Sundas, D., Tusconi, M., Pinna, F., et al. (2022) · European Psychiatry · doi:10.1192/j.eurpsy.2022.2333 · Cited by 12
Li, S., Liu, R., Sun, B., Wei, N., Shen, Z., Xu, Y., & Huang, M. (2022) · Brain Sciences · doi:10.3390/brainsci12111572 · Cited by 14
Jeppesen, R., Nilsson, A. C., Sørensen, N. V., Orlovska‐Waast, S., Christensen, R. H. B., & Benros, M. E. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2022.12.029 · Cited by 14
Identification of Homogeneous Subgroups from Resting-State fMRI Data
Yang, H., Vu, T., Long, Q., Calhoun, V. D., & Adalı, T. (2023) · Sensors · doi:10.3390/s23063264 · Cited by 14
Age‐related cognitive decline is accelerated in alcohol use disorder
Kurihara, K., Shiroma, A., Koda, M., Shinzato, H., Takaesu, Y., & Kondo, T. (2023) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12395 · Cited by 14
Harvey, P. D., Chirino, M., Mueller, A., Rivera-Molina, A., Zayas-Bazan, M., Kallestrup, P., & Czaja, S. J. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.115792 · Cited by 14
Li, Y., Ang, M. S., Yee, J. Y., See, Y. M., & Lee, J. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1444843 · Cited by 14
Libedinsky, I., Helwegen, K., Boonstra, J. T., Simón, L. G., Gruber, M., Repple, J., Kircher, T. T. J., Dannlowski, U., & van den Heuvel, M. P. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.10.007 · Cited by 14
Endothelial function, folate pharmacogenomics, and neurocognition in psychotic disorders
Grove, T. B., Taylor, S. F., Dalack, G. W., & Ellingrod, V. L. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.02.006 · Cited by 14
ADDing a piece to the puzzle of cognition in schizophrenia
Bosia, M., Pigoni, A., Zagato, L., Merlino, L., Casamassima, N., Lorenzi, C., Pirovano, A., Smeraldi, E., Manunta, P., & Cavallaro, R. (2015) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2015.12.012 · Cited by 14
The role of white matter microstructure in inhibitory deficits in patients with schizophrenia
Du, X. M., Kochunov, P., Summerfelt, A. T., Chiappelli, J., Choa, F., & Hong, L. E. (2016) · Brain stimulation · doi:10.1016/j.brs.2016.11.006 · Cited by 14
Mazhari, S., Ghafaree-Nejad, A. R., Soleymani-Zade, S., & Keefe, R. S. E. (2017) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2017.02.007 · Cited by 14
Almulla, A. F., Moustafa, S. R., Al-Dujaili, A. H., Al‐Hakeim, H. K., & Maes, M. H. J. (2020) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2020-0908 · Cited by 14
Symptomatic remission affects employment outcomes in schizophrenia patients
Wang, S., Wang, J., Chang, J., Wu, B.-J., Wang, T.-J., & Sun, H.-J. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02630-z · Cited by 15
Sachs, G., Lasser, I., Purdon, S. E., & Erfurth, A. (2021) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2021.100197 · Cited by 14
Duration Mismatch Negativity Predicts Remission in First-Episode Schizophrenia Patients
Nakajima, S., Higuchi, Y., Tateno, T., Sasabayashi, D., Mizukami, Y., Nishiyama, S., Takahashi, T., & Suzuki, M. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.777378 · Cited by 14
Déficit cognitivo en la esquizofrenia: MATRICS Consensus Cognitive Battery
Rodríguez–Jiménez, R., Bagney, A., Moreno-Ortega, M., García-Navarro, C., Aparicio, A. I., López‐Antón, R., de la Oliva, J., Arriero, M. Á. J., Santos, J. L., Lobo, A., et al. (2012) · Revista de Neurología · doi:10.33588/rn.5509.2012246 · Cited by 14
Brain structural changes and neuropsychological impairments in male polydipsic schizophrenia
Nagashima, T., Inoue, M., Kitamura, S., Kiuchi, K., Kosaka, J., Okada, K., Kishimoto, N., Taoka, T., Kichikawa, K., & Kishimoto, T. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-210 · Cited by 14
Pagsberg, A. K., Jeppesen, P., Klauber, D. G., Jensen, K. G., Rudå, D., Stentebjerg-Olesen, M., Jantzen, P., Rasmussen, S., Saldeen, E. A.-S., Lauritsen, M.-B. G., et al. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-199 · Cited by 14
Chen, Y., Wang, L., Lin, S., & Chen, C. (2015) · Substance Use & Misuse · doi:10.3109/10826084.2015.1050110 · Cited by 14
Counterfactual Reasoning Deficits in Schizophrenia Patients
Contreras, F., Albacete, À., Castellví, P., Caño, A., Benejam, B., & Menchón, J. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148440 · Cited by 14
The Screen for Cognitive Impairment in Psychiatry: Proposal for a polytomous scoring system
Gómez‐Benito, J., Berrío, Á. I., Guilera, G., Rojo, E., Purdon, S. E., & Pino, Ó. (2017) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1598 · Cited by 14
Xu, X., Liang, C., Lv, D., Yin, J., Luo, X., Fu, J., Yan, H., Zhou, X., Dai, Z., Zhu, D., et al. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00458 · Cited by 14
Randau, M., Oranje, B., Miyakoshi, M., Makeig, S., Fagerlund, B., Glenthoj, B. Y., & Bak, N. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101760 · Cited by 14
Hafiz, P., & Bardram, J. E. (2020) · JMIR mhealth and uhealth · doi:10.2196/17506 · Cited by 14
Frajo-Apor, B., Kemmler, G., Pardeller, S., Huber, M. K., Macina, C., Welte, A.-S., Hoertnagl, C. M., & Hofer, A. (2020) · European Psychiatry · doi:10.1192/j.eurpsy.2020.66 · Cited by 14
Shimada, T., Inagaki, Y., Shimooka, Y., Kawano, K., Tanaka, S., & Kobayashi, M. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.10.066 · Cited by 14
The multi-faceted, “global” cognitive impairment profile in schizophrenia
Dickinson, D., Schaefer, J. D., & Weinberger, D. R. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003872.003 · Cited by 13
Measurement based care in schizophrenia—Feasibility in routine clinical practice
Dinakaran, D., Sreeraj, V. S., & Venkatasubramanian, G. (2020) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2020.101954 · Cited by 13
Abplanalp, S. J., Mueser, K. T., & Fulford, D. (2021) · Psychological Assessment · doi:10.1037/pas0001080 · Cited by 13
Susai, S. R., Healy, C., Mongan, D., Heurich, M., Byrne, J. F., Cannon, M. D., Cagney, G., Wynne, K. J., Markulev, C., Schäfer, M. R., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02217-0 · Cited by 13
Cognitive deficits among people with schizophrenia and prediabetes or diabetes
John, A. P., Mya, T., & Haywood, D. (2023) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13627 · Cited by 13
Abel, D. B., Vohs, J. L., Salyers, M. P., Wu, W., & Minor, K. S. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.07.043 · Cited by 13
Increased Sensitivity to Effort and Perception of Effort in People with Schizophrenia
Culbreth, A. J., Chib, V. S., Riaz, S. S., Manohar, S., Husain, M., Waltz, J. A., & Gold, J. M. (2024) · Schizophrenia Bulletin · doi:10.1093/schbul/sbae162 · Cited by 13
Genes, Cognition, and Their Interplay in Methamphetamine Use Disorder
Khan, R., Turner, A., Berk, M., Walder, K. R., Rossell, S. L., Guerin, A. A., & Kim, J. H. (2025) · Biomolecules · doi:10.3390/biom15020306 · Cited by 15
Effects of risperidone and aripiprazole on neurocognitive rehabilitation for schizophrenia
Matsuda, Y., Sato, S., Iwata, K., Furukawa, S., Hatsuse, N., Watanabe, Y., Anzai, N., Kishimoto, T., & Ikebuchi, E. (2014) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12147 · Cited by 13
Antipsychotic treatments; focus on lurasidone
Sumiyoshi, T. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00102 · Cited by 13
COMT and STH polymorphisms interaction on cognition in schizophrenia
Bosia, M., Pigoni, A., Pirovano, A., Lorenzi, C., Spangaro, M., Buonocore, M., Bechi, M., Cocchi, F., Guglielmino, C., Bramanti, P., et al. (2014) · Neurological Sciences · doi:10.1007/s10072-014-1936-9 · Cited by 13
Verbal Memory Impairment in Patients with Subsyndromal Bipolar Disorder
Sumiyoshi, T., Toyomaki, A., Kawano, N., Kitajima, T., Kusumi, I., Ozaki, N., Iwata, N., Sueyoshi, K., & Nakagome, K. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00168 · Cited by 13
Huang, Y., Lin, P., Lee, Y., Hung, C., Hsu, S., Wu, C., & Wang, L. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s157055 · Cited by 13
Childhood trauma and cognitive functioning in individuals at clinical high risk (CHR) for psychosis
Velikonja, T., Velthorst, E., Zinberg, J. L., Cannon, T. D., Cornblatt, B. A., Perkins, D. O., Cadenhead, K. S., Tsuang, M. T., Addington, J., Woods, S. W., et al. (2020) · Development and Psychopathology · doi:10.1017/s095457941900155x · Cited by 15
Harvey, P. D., Forero, D. B., Ahern, L. B., Tibiriçá, L., Kallestrup, P., & Czaja, S. J. (2020) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2020.08.019 · Cited by 14
Assessment of brain cholesterol metabolism biomarker 24S-hydroxycholesterol in schizophrenia
Chiappelli, J., Quinton, M. S., Volfson, D., Cwik, M., Marshall, W., Bruce, H. A., Goldwaser, E. L., Kvarta, M. D., Summerfelt, A. T., Kochunov, P. V., et al. (2020) · Schizophrenia · doi:10.1038/s41537-020-00121-4 · Cited by 13
Takahashi, T., Sasabayashi, D., Takayanagi, Y., Higuchi, Y., Mizukami, Y., Nishiyama, S., Furuichi, A., Kido, M., Pham, T. V., Kobayashi, H., et al. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.647069 · Cited by 14
Real-time facial emotion recognition deficits across the psychosis spectrum: A B-SNIP Study
Rubin, L. H., Han, J., Coughlin, J. M., Hill, S. K., Bishop, J. R., Tamminga, C. A., Clementz, B. A., Pearlson, G. D., Keshavan, M. S., Gershon, E. S., et al. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.11.027 · Cited by 16
Metadata
- Authors
- Keefe, R.
- Affiliations
- Duke University (US)
- Corresponding author
- Keefe, R
- ORCID
- Keefe, R
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2004-06-01
- Volume
- 68
- Issue
- 2-3
- Pages
- 283-297
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W2008062633
- Cited by
- 1,573
- References
- 27
- Citations by year
- 2026: 100 · 2025: 129 · 2024: 115 · 2023: 96 · 2022: 107 · 2021: 130 · 2020: 129 · 2019: 105 · 2018: 90 · 2017: 89 · 2016: 83 · 2015: 82 · 2014: 62 · 2013: 65 · 2012: 44
- FWCI
- 4.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Schizophrenia Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Applied Psychology › Psychological Testing and Assessment
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Keywords
- Brief Assessment of Cognition in Schizophrenia, schizophrenia
- MeSH terms
- Adult, Clinical Trials as Topic, Cognition Disorders, Female, Humans, Male, Neuropsychological Tests, Practice, Psychological, Psychometrics, Research Design, Schizophrenia, Schizophrenic Psychology, Sensitivity and Specificity, Antipsychotic Agents, Reproducibility of Results
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
